Intravenous γ-globulin treatment in a patient with subacute sclerosing panencephalitis

Pediatric Neurology

Volumn 14, Issue 1, 1996, Pages 72-74

  Gürer, Y K Yavuz ^a,b   Kükner, Şenay ^a   Sarica, Bige ^a  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHISOPRINOL;

CASE REPORT; CHILD; DISEASE COURSE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0342313455     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/0887-8994(95)00257-X     Document Type: Article

References (11)

1. Dunn RA. Subacute sclerosing panencephalitis. Pediatr Infect Dis J 1991;10:68-72.
2. Dyken PR. Subacute sclerosing panencephalitis. Neurol Clin 1985;3:179-95.
3. Risk WS, Haddad FS, Chemali R. Substantial spontaneous long-term improvement in subacute sclerosing panencephalitis: Six cases from the Middle East and a review of the literature. Arch Neurol 1987;35: 494-502.
4. Yalaz K, Anlar B, Oktem F. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 1992;42:488-91.
5. Miyazaki M, Hashimoto T, Fujino K. Apparent response of sub-acute sclerosing panencephalitis to intrathecal interferon alpha. Ann Neurol 1991;29:97-9.
6. Dyken PR, Dotson PM, Maertens P. The Neurological Disability Index in subacute sclerosing panencephalitis. In: Bergamini F, Defanti CA, Ferrante P, eds. Subacute sclerosing panencephalitis: A reappraisal. New York: Elsevier Science, 1986:109-16.
7. Shaikih NJ, Rodrigues JJ. Serological studies on subacute sclerosing panencephalitis. Indian J Pediatr 1991;58:833-5.
8. Crespi M, Chiu MN, Schoub BT, Lyons SF. Effect of interferon on Vero cells persistently infected with SSPE virus and lytically infected with measles virus. Arch Virol 1986;90:87-96.
9. The Inosiplex-SSPE Research Committee. Clinical effects of MND-19 (inosiplex) on subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 1982;11:359-64.
10. Panitch HS, Gomex-Plascencia J, Norris FH. Subacute sclerosing panencephalitis: Remission after treatment with intraventricular interferon. Neurology 1986;36:562-6.
11. Shatar E, Murphy GE, Roifman CM. Benefit of intravenously administered immune serum globuline in patients in Guillain Barrè syndrome. J Pediatr 1990;116:140-1.